Saskatchewan Health Research Foundation (SHRF)’s Post

Inspired by our Christian mission, Baylor's Robbins College of Health and Human Sciences seeks to enhance health, quality of life, and human flourishing for all individuals and communities. In 2023—after a year-long collaboration of College faculty, staff, and leadership—announced the Signature Research Initiatives that would undergird this aspiration: Behavioral and Human Sciences, Chronic Diseases and Conditions, Health Access and Quality, and (Re)habilitative Sciences. https://lnkd.in/gbGPbuNP

Check out this article I wrote!

CTE (chronic traumatic encephalopathy) continues to be a rapidly evolving topic in health care and legislation, as we are beginning to understand the magnitude of multiple brain injuries. I feel honoured to be an alumni of BU and inspired by the ground breaking research they continue to do to help us all better understand CTE. A great read on what we now know about CTE.

In our ever-evolving world, simply excelling in your role is no longer enough. It’s about creating a lasting impact. 🌍 🏆 While some may prioritize titles over teamwork, true leadership is about fostering growth and ensuring the future success of both people and organizations. It’s essential to remember that mentorship can significantly alter team dynamics and long-term outcomes. A staggering 75% of executives credit mentoring as a pivotal part of their journey, and companies with robust mentoring programs report a 72% boost in productivity. 👥 Effective leadership goes beyond immediate results. It involves nurturing talents and preparing the next generation to lead. Unfortunately, not all managers prioritize this, sometimes due to misplaced priorities or misguided loyalty from higher-ups. This underscores the importance of aligning leadership with both current performance and future potential. It’s uplifting to see many organizations embracing the value of interns and young professionals, demonstrating commitment to long-term success over short-term gains. I love seeing across LinkedIn the shout outs to interns as well as mentors who are investing their time and effort into developing future generations. How are you making a difference in nurturing future leaders? Join the conversation below! 💬👇 #hailtopitt #mentor #futurebusinessleaders #mentorship #leadership #pittsburgh #pittsburghbusiness #realestate

School OTPs - consider sharing your evidence based practice and research at this conference!

In case you missed it, at our most recent EPA webinar the ABS was joined by program leaders from Ascension St. John, Indiana University, Louisiana State University New Orleans, Medical College of Wisconsin, Mt. Sinai NYC, and University of Wisconsin, to discuss how their residency programs have implemented the EPA framework, navigated challenges, and what they have done to make the initiative so successful at their institution. Watch the recording here: https://lnkd.in/ggyrzhvW

It was great to be interviewed about our current collaboration within the EU-funded TACT: Targeted Anti-Cancer Therapies consortium. Thanks to a focused collaboration with Chris Scott, Vijay Chudasama, and Sarah Cianferani, our own PhD-student Irene Shajan -with the help of Léa Rochet, Bianka Gabriela Jackowska, Rania Benazza, Oscar Hernandez Alba, and Floris van Delft- developed a platform that allows the conversion of monoclonal antibodies into very potent bispecific constructs. And with very potent I mean displaying IC50 values in the low picomolar range! Better still, they're not toxic!! The activity is directly connected to the covalent linkage between the units, the separated components don't do anything. Great to share this outcome. Here is a link to the paper: https://lnkd.in/e-bWBApD If you're interested, keep your eyes open for another paper that will be submitted later this year. Also, we will have positions available soon to extend this research further.

🌍✨Today, May 20th, we celebrate International Clinical Trials Day, marking the anniversary of the first clinical trial by Scottish physician James Lind aboard the HMS Salisbury in 1747. Lind's pioneering work laid the foundation for modern clinical research.✨🌍 🍋 In the 18th century, scurvy was a deadly threat to sailors, caused by a lack of vitamin C. It devastated entire fleets and claimed more lives at sea than all other diseases, shipwrecks, or battles combined. ⚓ James Lind, a surgeon on the HMS Salisbury, was determined to find a cure. He selected 12 sailors with scurvy, divided them into pairs, and tested six treatments, including citrus fruits. The men who received citrus showed significant improvement within a week. 💡 Lind’s work illustrates the importance of experimentation in medical science, paving the way for today's controlled clinical trials. 🎆 💊 As we celebrate International Clinical Trials Day, we honor James Lind and all researchers dedicated to advancing medical science. Their work saves lives and improves the quality of life worldwide. 👨🏽⚕️ 👩🏽⚕️ At DocNexus we are proud to play a small role in helping connect scientists to usher in the next-generation of life-saving medicines and clinical research! #InternationalClinicalTrialsDay #HealthcareHeroes #MedicalInnovation #JamesLind #FightAgainstScurvy

👋 Meet ORS Member Dr. Alayna E. Loiselle, Associate Professor and Principal Investigator at the University of Rochester Medical Center. Her research focuses on tendon fibrosis and regeneration. As a Kappa Delta Young Investigator and Adele L. Boskey awardee, she advises: 'be comfortable putting yourself out there … I would much rather have someone actively tell me 'No', than to wonder what would have happened if I had not put myself out there.' Learn more about Dr. Loiselle in this video. https://lnkd.in/dBDuzSx6

 🌐Exciting times at CNIC   📹 Our latest video dives deep into groundbreaking research to fight against the #1 killer: Cardiovascular Disease (CDV) 🔬 ❤️ 👨🔬     💡 To meet this challenge, the CNIC has defined three key goals:   - To deepen and extend our understanding of cardiovascular health   - To optimize disease prevention   - To develop advanced and innovative treatments for the most prevalent cardiovascular disorders.   ➡ Achieving these goals requires advanced research that provides detailed information on the molecular and cellular processes that underlie the disease. But it is also essential that these advances can be translated into improved health promotion, diagnosis, and treatment.   ✊ To meet these challenges, the CNIC has had to adapt.   We have moved on from a structure based on three research areas to one built around seven research programs. These programs embrace approaches from basic research to advanced clinical trials that deliver real health benefits and are built upon proven experience and rooted in advanced technological expertise in cell and animal models, imaging modalities, and massive data processing and analysis.     Watch now:   https://lnkd.in/dkGb4zeP